Cargando…

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD

Background: Prospective pharmacological studies on breathomics profiles in COPD patients have not been previously reported. We assessed the effects of treatment and withdrawal of an extrafine inhaled corticosteroid (ICS)-long-acting β(2)-agonist (LABA) fixed dose combination (FDC) using a multidimen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montuschi, Paolo, Santini, Giuseppe, Mores, Nadia, Vignoli, Alessia, Macagno, Francesco, Shoreh, Rugia, Tenori, Leonardo, Zini, Gina, Fuso, Leonello, Mondino, Chiara, Di Natale, Corrado, D'Amico, Arnaldo, Luchinat, Claudio, Barnes, Peter J., Higenbottam, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914154/ https://www.ncbi.nlm.nih.gov/pubmed/29719507 http://dx.doi.org/10.3389/fphar.2018.00258

Ejemplares similares

New Pharmacologic Perspectives in Pneumology: Beclomethasone-Formoterol Extrafine
por: Paggiaro, Pierluigi
Publicado: (2009)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
por: Nicolini, Gabriele, et al.
Publicado: (2008)

Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD
por: Singh, Dave, et al.
Publicado: (2014)

Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients
por: Tzani, Panagiota, et al.
Publicado: (2011)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018)

Development of Room Temperature Stable Formulation of Formoterol Fumarate/Beclomethasone HFA pMDI
por: Purohit, D., et al.
Publicado: (2009)

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways
por: Calzetta, Luigino, et al.
Publicado: (2018)

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study
por: Wright, Caroline E., et al.
Publicado: (2017)

Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD Patients
por: Pisi, Roberta, et al.
Publicado: (2021)

Human Breathomics Database
por: Kuo, Tien-Chueh, et al.
Publicado: (2020)

Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
por: Hasan, Ashfaq, et al.
Publicado: (2021)

Metabolomic Analysis by Nuclear Magnetic Resonance Spectroscopy as a New Approach to Understanding Inflammation and Monitoring of Pharmacological Therapy in Children and Young Adults With Cystic Fibrosis
por: Montuschi, Paolo, et al.
Publicado: (2018)

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
por: Singh, Dave, et al.
Publicado: (2017)

Lung Deposition of Inhaled Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide in Healthy Volunteers and Asthma: The STORM Study
por: Usmani, Omar S., et al.
Publicado: (2022)

Breathomics in Asthmatic Children Treated with Inhaled Corticosteroids
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Differential Network Analysis Reveals Molecular Determinants Associated with Blood Pressure and Heart Rate in Healthy Subjects
por: Vignoli, Alessia, et al.
Publicado: (2020)

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
por: O'Connor, Brian J, et al.
Publicado: (2011)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study
por: Singh, Dave, et al.
Publicado: (2017)

Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease
por: Pelaia, Corrado, et al.
Publicado: (2023)

Modern Inflammatory Phenotyping of Asthma. Breathomics Is Here to Stay
por: Sterk, Peter J.
Publicado: (2019)

Exploration of Blood Lipoprotein and Lipid Fraction Profiles in Healthy Subjects through Integrated Univariate, Multivariate, and Network Analysis Reveals Association of Lipase Activity and Cholesterol Esterification with Sex and Age
por: Balder, Yasmijn, et al.
Publicado: (2021)

Breathomics – the Way Forward Towards a Mask Free World
por: Banerjee, Mithu, et al.
Publicado: (2022)

Exploration of Blood Metabolite Signatures of Colorectal Cancer and Polyposis through Integrated Statistical and Network Analysis
por: Di Cesare, Francesca, et al.
Publicado: (2023)

Breathomics for Gastric Cancer Classification Using Back-propagation Neural Network
por: Daniel, D. Arul Pon, et al.
Publicado: (2016)

Cross-platform mass spectrometry annotation in breathomics of oesophageal-gastric cancer
por: Chin, Sung-Tong, et al.
Publicado: (2018)

Trends in the Development of Electronic Noses Based on Carbon Nanotubes Chemiresistors for Breathomics
por: Freddi, Sonia, et al.
Publicado: (2022)

Breathomics profiling of metabolic pathways affected by major depression: Possibilities and limitations
por: Gbaoui, Laila, et al.
Publicado: (2022)

Serum or Plasma (and Which Plasma), That Is the Question
por: Vignoli, Alessia, et al.
Publicado: (2022)

Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial
por: Beeh, Kai-Michael, et al.
Publicado: (2021)

A Review of Analytical Techniques and Their Application in Disease Diagnosis in Breathomics and Salivaomics Research
por: Beale, David J., et al.
Publicado: (2016)

Exhaled Biomarkers for Point-of-Care Diagnosis: Recent Advances and New Challenges in Breathomics
por: Kiss, Helga, et al.
Publicado: (2023)

Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects
por: Malerba, Mario, et al.
Publicado: (2018)

Exploring the performance of a functionalized CNT-based sensor array for breathomics through clustering and classification algorithms: from gas sensing of selective biomarkers to discrimination of chronic obstructive pulmonary disease
por: Drera, Giovanni, et al.
Publicado: (2021)

Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis
por: Liu, Ting, et al.
Publicado: (2021)

A cross-sectional study: a breathomics based pulmonary tuberculosis detection method
por: Fu, Liang, et al.
Publicado: (2023)

On-demand intermittent beclomethasone is effective for mild asthma in Brazil
por: Camargos, Paulo, et al.
Publicado: (2018)

Compatibility and aerosol characteristics of beclomethasone mixed with N-acetylcysteine
por: Wu, Xiufeng, et al.
Publicado: (2023)

High‐Throughput Metabolomics by 1D NMR
por: Vignoli, Alessia, et al.
Publicado: (2018)

Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study
por: Wang, Peiyu, et al.
Publicado: (2022)

Effect of nasal beclomethasone spray in the treatment of otitis media with effusion
por: Barati, Behrooz, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_83ornepp1oidcg6ecpglaioeca